Patent · US Active

Methods of inhibiting plasma kallikrein in edema patient

US10336832B2 · kind B2 · utility

9Cited by
158References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2014
Grant dateJul 2, 2019
Priority date—
Expiry dateJun 19, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Plasma kallikrein binding proteins and methods of using such proteins are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.